Organoids illuminate NAFLD pathogenesis
- PMID: 36899272
- DOI: 10.1038/d41573-023-00047-3
Organoids illuminate NAFLD pathogenesis
Keywords: Biotechnology; Drug discovery; Molecular biology; Therapeutics.
Comment on
-
Engineered human hepatocyte organoids enable CRISPR-based target discovery and drug screening for steatosis.Nat Biotechnol. 2023 Nov;41(11):1567-1581. doi: 10.1038/s41587-023-01680-4. Epub 2023 Feb 23. Nat Biotechnol. 2023. PMID: 36823355 Free PMC article.
References
-
- Hendriks, D. et al. Engineered human hepatocyte organoids enable CRISPR-based target discovery and drug screening for steatosis. Nat. Biotechnol. https://doi.org/10.1038/s41587-023-01680-4 (2023)
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
